Nuzenio

But Full On

But Full On news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 9 publisher sources 100/100 entity strength

Latest news

FB Financial (FBK) Stock Looks Cheap On Fair Value But Full On Earnings - simplywall.stsimplywall.st · Mon, 10 Aug 2026 00:37:54 GMTIran says Hormuz shipping deal with Oman close, but full reopening still conditional - DailynewsegyptDailynewsegypt · Sun, 09 Aug 2026 18:50:44 GMTTake-Two’s (NASDAQ:TTWO) Q2 CY2026 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations Significantly - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 12:36:56 GMTCVRX: Q2 revenue up 16% year-over-year, but full-year outlook lowered amid sales and payer headwinds - TradingViewTradingView · Thu, 06 Aug 2026 20:07:43 GMTASTE: Sales up 23.6%, backlog up 57.9%, but full-year EBITDA guidance revised downward - TradingViewTradingView · Wed, 05 Aug 2026 11:20:56 GMTBio-Rad Earnings: Modest Sequential Improvement, but Full-Year Guidance Ranges Remain Wide - MorningstarMorningstar · Wed, 05 Aug 2026 07:00:00 GMTTransMedics Group (TMDX) Stock Looks Cheap On Earnings But Full After 171% Gain - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 06:09:00 GMTAmerican Express (AXP) Stock Looks Cheap On Fair Value But Full On Earnings - webull.comwebull.com · Mon, 03 Aug 2026 12:17:26 GMT

Timeline

Mon, 10 Aug 2026 00:37:54 GMTFB Financial (FBK) Stock Looks Cheap On Fair Value But Full On Earnings - simplywall.st
Sun, 09 Aug 2026 18:50:44 GMTIran says Hormuz shipping deal with Oman close, but full reopening still conditional - Dailynewsegypt
Fri, 07 Aug 2026 12:36:56 GMTTake-Two’s (NASDAQ:TTWO) Q2 CY2026 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations Significantly - Yahoo Finance
Thu, 06 Aug 2026 20:07:43 GMTCVRX: Q2 revenue up 16% year-over-year, but full-year outlook lowered amid sales and payer headwinds - TradingView
Wed, 05 Aug 2026 11:20:56 GMTASTE: Sales up 23.6%, backlog up 57.9%, but full-year EBITDA guidance revised downward - TradingView
Wed, 05 Aug 2026 07:00:00 GMTBio-Rad Earnings: Modest Sequential Improvement, but Full-Year Guidance Ranges Remain Wide - Morningstar

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for But Full On.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.